We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Training Using Feuerstein Instrumental Enrichment (Feuerstein)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02774083
Recruitment Status : Completed
First Posted : May 17, 2016
Last Update Posted : September 24, 2019
Sponsor:
Collaborators:
Adolf und Mary Mil-Stiftung
Helen Bader Foundation
Montreal Jewish Community Fund
Rochlin Family Foundation
Information provided by (Responsible Party):
Tzvi Dwolatzky, Rambam Health Care Campus

Brief Summary:

Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental deterioration and preserve cognitive abilities among people aged 60 and above. The program is an applied practicable program based on the theories of Structural Cognitive Modifiability as well as on a Mediated Learning Experience. The program takes into consideration the unique characteristics and requirements of the older population. The program is composed of a variety of cognitive tasks that offer systematic activities intended to stimulate mental and cognitive development.

Objective: To examine the influence of the Feuerstein Program on the cognitive function and well-being of participants suffering from Mild Cognitive Impairment (MCI).

Hypothesis: The Feuerstein Program will improve cognitive abilities and functional well-being of the participants.

Methods: Residents of retirement homes will be offered to participate in the research. Participants will undergo cognitive and functional assessments that will be carried out on four specific dates. The participants of the Intervention Group will participate in the Feuerstein program using a method of mediated learning while the Control Group will participate in a program of the Adler Institute involving activities aimed at social and emotional development without specific cognitive skill training.


Condition or disease Intervention/treatment Phase
Mild Cognitive Impairment Behavioral: Feuerstein Program Behavioral: Adler Program Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 26 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Prevention
Official Title: An Evaluation of the Feuerstein Instrumental Enrichment Program for the Cognitive Enhancement of Older People With Mild Cognitive Impairment (MCI) Living in the Community
Actual Study Start Date : September 3, 2015
Actual Primary Completion Date : May 31, 2016
Actual Study Completion Date : May 31, 2016

Arm Intervention/treatment
Active Comparator: Feuerstein Program
The participants of the Intervention Group will participate in the Feuerstein mediated learning cognitive program.
Behavioral: Feuerstein Program
Mediated learning cognitive enhancement program

Placebo Comparator: Adler Program
The Control Group will participate in the program of the Adler Institute dealing with social and emotional development without specific cognitive skills training.
Behavioral: Adler Program
Social and emotional group program




Primary Outcome Measures :
  1. Change from baseline cognitive function [ Time Frame: Through study completion, an average of 6 months ]
    Based on Neurotrax computerized neuropsychological assessment battery



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Aged 60 and above.
  2. Hebrew/English speakers.
  3. Expressing willingness to participate in the research and deliberately signing a consent form.
  4. A diagnosis of MCI exists according to accepted clinical criteria - the examinee's score in the MoCA Test is within the range of 18-26 (inclusive).

Exclusion Criteria:

  1. A medical or functional condition that will not allow the patient to participate in the intervention program within the research period.
  2. Diagnosed patients suffering from depression, bipolar disorder or schizophrenia.
  3. Patients who suffer from a diagnosed cognitive impairment other than MCI (delirium dementia or mental retardation).
  4. Visual impairment that hasn't been amended by glasses.
  5. Hearing impairment that hasn't been amended by a hearing aid.
  6. Examinees whose MoCA Test's score is 17 and below or 27 and above.
  7. Examinees who will receive the maximal score in one or more sections of the Lawton Test.
  8. Examinees who will respond positively to a filter question regarding the topic of depression.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02774083


Locations
Layout table for location information
Israel
Beit Yona
Beersheba, Israel
Ramat Tamir Retirement Home
Jerusalem, Israel, 91450
Beit Tovei Hair
Jerusalem, Israel, 9550100
Bayit Balev Beit Ildan
Qiryat Moẕqin, Israel, 2640143
Bayit Balev Tel Aviv
Tel Aviv, Israel
Sponsors and Collaborators
Rambam Health Care Campus
Adolf und Mary Mil-Stiftung
Helen Bader Foundation
Montreal Jewish Community Fund
Rochlin Family Foundation
Investigators
Layout table for investigator information
Principal Investigator: Tzvi Dwolatzky, MD MBBCh Rambam Health Care Campus
Publications:
Layout table for additonal information
Responsible Party: Tzvi Dwolatzky, Prof. Tzvi Dwolatzky, Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT02774083    
Other Study ID Numbers: RMC_TD_23/2015
First Posted: May 17, 2016    Key Record Dates
Last Update Posted: September 24, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Tzvi Dwolatzky, Rambam Health Care Campus:
older people
cognitive training
Additional relevant MeSH terms:
Layout table for MeSH terms
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders